251-260 of 588 results for 'consumer data right'

Metaverse, VR and AR: what you need to know
Insight 28 Jun 2023

The digital world is rapidly transforming and, with the metaverse and other virtual technologies coming to prominence, this transformation is only going to accelerate. To stay ahead of the curve, businesses need to understand what's ahead, the coming changes and what these mean in practice. ...

Class action risk: interim update 2024
Insight 18 Jul 2024

In this interim report we provide a high-level overview of class action filings over the first half of the year and highlight several factors that are poised to shape the class action landscape moving forward. ...

ChatGPT in law: unlocking new opportunities while managing the risks
Insight 15 Feb 2023

As legal professionals around the globe settle into another year of work, they have been confronted by a new existential threat from OpenAI's much discussed AI chatbot, ChatGPT. Many lawyers have been asking similar questions: will my job exist this time next year? How accurate is it at answering th ...

ASIC and APRA announce strategic priorities
Insight 30 Aug 2023

In this Insight, we consider the key trends, similarities and differences we have observed across ASIC and APRA's Corporate Plan. We also explain what to expect on the regulators' supervision and enforcement agendas in the near future. ...

COVIDSafe – what we now know
Insight 27 Apr 2020

On Sunday, the Australian Government launched its voluntary digital contact tracing app 'COVIDSafe', along with the app's Privacy Policy, an independent Privacy Impact Assessment (PIA) and the Department of Health's response to that PIA. The Chief Medical Officer has predicted that the application will have been downloaded more than 2 million times by the end of Monday. ...

Repurposing existing medicines – industry to have its say in reshaping Australia's regulatory future
Insight 25 Mar 2021

The Therapeutics Goods Administration (the TGA) is consulting with the public and industry to potentially reform regulatory and reimbursement frameworks, to incentivise the repurposing of existing medicines. Off-label use (where a medicine is used for a disease or medical condition for which it does ...

Using tech and data in a crisis – contact tracing
Insight 09 Apr 2020

Data analysis, and the technology that facilitates it, is currently playing a critical role in the global and national efforts to combat the COVID-19 pandemic. Alongside the front-line health response, it has become a core part of the daily calculations made by governments and health organisations. ...

Federal Budget 2023–24: five key takeaways for general counsel
Insight 17 May 2023

Here is our take on the essential issues for General Counsel arising from the Federal Budget (Budget) 2023-24. ...

Merger reform legislation: complex process risks capturing more transactions than intended
Insight 11 Oct 2024

Yesterday, the Federal Government introduced the Treasury Laws Amendment (Mergers and Acquisitions Reform) Bill 2024 (the Bill) to the Parliament, marking a significant shift in Australia's merger reg ...

Class action risk: interim update
Insight 04 Aug 2023

Class action filings in 2023 are on pace to significantly outstrip the number of claims filed last year, reverting to the trend of elevated filings seen over recent record setting years. ...

Refine